Literature DB >> 18297370

Otitis externa: quality of life assessment.

R Ali1, P Burns, M Donnelly.   

Abstract

INTRODUCTION: Otitis externa (OE) is an extremely common dermatological condition that can affect social life and employment, but formal studies of its general health impact are lacking.
OBJECTIVE: The aims of this study were two-folded, first to assess the impact of OE on various health determinants as measured by the Finlay's dermatological quality of life index (DLQI) and second to see if there was any difference on quality of life (QoL) of patients with acute and chronic OE.
METHODS: A prospective questionnaire study was carried out. The study included 85 consecutive adult patients with both acute and chronic OE attending the casualty department of a regional otolaryngology unit.
RESULTS: Both groups of patients reported a significantly poor QoL, particularly patients with acute OE, whom were significantly affected by the condition.
CONCLUSION: We concluded that OE has a significant impact on the QoL particularly in patients with acute and chronic OE.

Entities:  

Mesh:

Year:  2008        PMID: 18297370     DOI: 10.1007/s11845-008-0137-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  4 in total

Review 1.  10 years experience of the Dermatology Life Quality Index (DLQI).

Authors:  Victoria Lewis; Andrew Y Finlay
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

Review 2.  Otitis externa: Review and clinical update.

Authors:  J David Osguthorpe; David R Nielsen
Journal:  Am Fam Physician       Date:  2006-11-01       Impact factor: 3.292

3.  Translating the science of quality of life into practice: What do dermatology life quality index scores mean?

Authors:  Yan Hongbo; Charles L Thomas; Michael A Harrison; M Sam Salek; Andrew Y Finlay
Journal:  J Invest Dermatol       Date:  2005-10       Impact factor: 8.551

4.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.